We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT) (ZU-HVA-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00742794
Recruitment Status : Completed
First Posted : August 28, 2008
Last Update Posted : August 19, 2010
Information provided by:
University of Zurich

Brief Summary:
In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Condition or disease Intervention/treatment Phase
Hymenoptera Sting Allergy Other: Observation Phase 4

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects
Study Start Date : August 2008
Study Completion Date : August 2010

Group/Cohort Intervention/treatment
Hymenoptera sting allergic patients under immunotherapy
Other: Observation
Observation of sting frequency

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   5 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Hymenoptera sting allergic patients under allergen specific immunotherapy

Inclusion criteria:

  • Bee and/or Wasp allergic patients treated by SIT

Exclusion criteria:

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00742794

Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich

Responsible Party: G.Senti, University of Zurich
ClinicalTrials.gov Identifier: NCT00742794     History of Changes
Other Study ID Numbers: ZU-HVA-001
First Posted: August 28, 2008    Key Record Dates
Last Update Posted: August 19, 2010
Last Verified: September 2008

Additional relevant MeSH terms:
Bites and Stings
Chemically-Induced Disorders
Wounds and Injuries